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Following implantation, the human embryo undergoes major morphogenetic transformations
that establish the future body plan. While the molecular events underpinning this process are
established in mice, they remain unknown in humans. Here we characterise key events of
human embryo morphogenesis, in the period between implantation and gastrulation, using
single-cell analyses and functional studies. First, the embryonic epiblast cells transition
through different pluripotent states and act as a source of FGF signals that ensure pro-
liferation of both embryonic and extra-embryonic tissues. In a subset of embryos, we identify
a group of asymmetrically positioned extra-embryonic hypoblast cells expressing inhibitors of
BMP, NODAL and WNT signalling pathways. We suggest that this group of cells can act as
the anterior singalling centre to pattern the epiblast. These results provide insights into
pluripotency state transitions, the role of FGF signalling and the specification of
anterior-posterior axis during human embryo development.
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The development of the human embryo during the secondweek of gestation represents a critical stage of embry-ogenesis as the free-floating blastocyst implants into the
maternal endometrium while undergoing major morphogenetic
transformations in preparation for the subsequent phase of gas-
trulation (14 days post-fertilisation (d.p.f.)). Key events include
the transition in the pluripotency state and generation of the
post-implantation embryonic epiblast epithelium, followed by a
symmetry-breaking event that leads to the formation of the
anterior–posterior (AP) body axis1–5. Concomitantly, the extra-
embryonic tissues undergo a global reorganisation, with the
hypoblast making the primary yolk sac and the trophoblast dif-
ferentiating into the major cell types of the placenta. These
morphogenetic transformations need to be tightly coordinated.
Failure of development during this time represents one of the
major causes of early pregnancy loss in patients undergoing
assisted conception treatements6. Despite this relevance, we
currently lack a functional understanding of the molecular and
cellular mechanisms governing this stage of human development.
Although embryo development is not amenable to in vivo
research in humans, the use of model systems such as mouse and
monkey has led to the identification of the molecular and cellular
mechanisms that drive symmetry breaking and specification of
the AP axis7–13. In mouse embryos, a subset of distal extra-
embryonic endoderm cells is specified as the distal visceral
endoderm (DVE), which migrates towards the future anterior
domain giving rise to the anterior visceral endoderm (AVE)14–19.
These AVE cells secrete NODAL, BMP and WNT inhibitors,
leading to a gradient of signalling activity across the epiblast that
defines the AP axis13. Interestingly, in cynomolgus monkey
embryos, all hypoblast cells initially express the BMP inhibitor
CER1, which progressively becomes restricted to the anterior side
of the embryo11. These findings indicate that the mechanisms
leading to symmetry breaking are not completely conserved
across species, and raise the question of how epiblast patterning is
initiated in human embryos.
The recent establishment of methods to culture human
embryos beyond implantation in vitro offers an unprecedented
opportunity to characterise the molecular and cellular transfor-
mations that human embryos undergo during the second week of
development20–22. These methodologies have been used to
describe the transcriptional profiles of embryos at different stages
of development23–25. However, functional and in-depth char-
acterisation experiments to determine how signalling interactions
between embryonic and extra-embryonic cells reshape the
developing human embryo are lacking.
Here, we combine single-cell sequencing and functional
experiments to investigate the signalling interactions between
embryonic and extra-embryonic cells that underlie the develop-
ment of the in vitro cultured human embryo between implanta-
tion and gastrulation. We observe that the epiblast transitions
through different pluripotent states and acts as a source of FGF
signals necessary for proliferation of all the lineages during early
post-implantation development. At 9 d.p.f., a subset of hypoblast
cells reminiscent of the anterior visceral endoderm in the pre-
gastrulation mouse embryo emerges. These cells secrete con-
served inhibitors of the NODAL, BMP and WNT signalling
pathways, and could initiate patterning of the anterior-posterior
axis prior to gastrulation.
Results
Single-cell RNA sequencing of human embryos at 9 and 11 d.p.f.
To determine the spatio-temporal gene expression profile of the
human embryo beyond implantation, we cultured blastocysts,
donated from patients undergoing in vitro fertilisation (IVF)
treatment, from day 5 d.p.f. until 9 and 11 d.p.f. . We analysed a
total of 29 embryos by single-cell RNA sequencing (scRNA-seq)
using 10x Genomics Chromium26 (Supplementary Data 1). 13 out
of 29 embryos lacked inner cell mass (ICM) derivatives, either
embryonic epiblast cells or extra-embryonic hypoblast cells, and
were therefore excluded from downstream analyses. Our final
dataset comprised 16 embryos (8 at 9 d.p.f. and 8 at 11 d.p.f.) and a
total of 4820 cells (Supplementary Fig. 1a–g, Supplementary
Data 1).
We defined four distinct clusters based on the expression of
known markers (Fig. 1a): the epiblast, precursor of the embryo
proper (cluster 1, 166 cells), the hypoblast, precursor of the yolk
sac (cluster 2, 136 cells), and the trophoblast, which mediates
implantation of the embryo into the maternal endometrium and
contributes to the formation of the placenta (clusters 3–4). Based
on differential expression gene analysis, we highlighted the most
significantly enriched genes defining each lineage (Fig. 1b, bold
red, Supplementary Data 2, Supplementary Fig. 2a–d). The
epiblast was characterised by the expression of the canonical
pluripotency genes POU5F1, NANOG and SOX2, as well as other
markers such as DPPA5, KHDC1L, MT1X, KHDC3L and MT1G.
The hypoblast could be distinguished by the expression of the
canonical markers PDGFRA and GATA6, alongside other genes
such as APOA1, FN1, S100A14, COL4A1 and APOA2. The
trophoblast appeared to develop into two subpopulations: the
cytotrophoblast lineage (cluster 3, 2182 cells), identified by
the expression of PEG10, FABP5, HIST1H4C, KRT19, TPM1, the
E-CADHERIN gene CDH1 and the integrin subunit ITGA6; and
the syncytiotrophoblast (cluster 4, 2336 cells), marked by the
expression of the markers CGA, PRR9, ANXA1, LGALS16 and
ATF3, similar to expression profiles reported elsewhere27–31.
Interestingly, the mouse trophoblast marker EOMES was not
detected in agreement with previous findings in human23,24
(Supplementary Fig. 2 e, f) and monkey embryos8 (Supplemen-
tary Fig. 2 g, h). Next, we projected previously published single
cell expression profiles of human embryos cultured in vitro at
equivalent stages using a logistic regression model trained on our
embryo data23,24. This analysis revealed a high cluster similarity
between the datasets (Supplementary Fig. 3a, b) and confirmed
the identification of the major cell types present in post-
implantation human embryos. We provide an open-source web
server at www.humanembryo.org (see ‘Methods’).
Pluripotency transition from pre to post-implantation. Exit
from the unrestricted naïve pluripotent state and transition to
the lineage-biased primed pluripotent state occurs in mouse and
monkey epiblasts as the embryo develops from pre- to post-
implantation7,8. This transition is required for correct morpho-
genesis of the epiblast lineage following implantation32. To
characterise the transcriptional changes associated with plur-
ipotency transition in the human embryo developing in culture,
we integrated our post-implantation epiblast datasets at 9 and 11
d.p.f. with recently generated single-cell datasets corresponding to
the pre-implantation ICM at 5 d.p.f. and epiblast at 6-7 d.p.f.33–36
(Fig. 1c, Supplementary Data 4). We found that major naïve
markers KLF4, KLF17, PRDM14, DNMT3L, SOX15, TFCP2L1,
ZFP42 were all highly expressed in the pre-implantation epiblast
and became downregulated post-implantation at 9 and 11 d.p.f.
(Fig. 1d). An exception was the gene UTF1, which became upre-
gulated instead. Conversely, major primed pluripotency markers
FGF2, DNMT3B, SOX11, SFRP2 and SALL2 showed an increased
expression in the post-implantation epiblast (Fig. 1e). The mouse
early post-implantation epiblast markers FGF5 and OTX237,38
exhibited low expression levels in ICM and epiblast cells
throughout the different developmental states. Interestingly,
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NODAL exhibited a downward trend during this developmental
time-window. All the core pluripotency markers POU5F1,
NANOG and SOX2 showed a steady upregulation as the epiblast
transited from pre- to post-implantation (Fig. 1f), in agreement
with a recent scRNA-seq dataset23 (Supplementary Fig. 4a, b).
A variety of protocols have been developed to derive human
embryonic stem cells (ESCs) reflecting different pluripotency
states3,39–42. To address whether these different cell types
correspond to different stages of embryo development, we used
logistic regression analysis to project human ESCs cultured
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under different regimes onto the pre- and post-implantation
epiblast43–45 (Fig. 1g, Supplementary Fig. 5a, b). Despite
similarities with both pre and post-implantation stages, conven-
tional primed ESCs (H9) shared transcriptional similarities with
the post-implantation human epiblast at 11 d.p.f., while recently
generated naïve human ESCs43 (H9-Reset) more closely
resembled the pre-implantation epiblast at 6–7 d.p.f. (Fig. 1g).
When these cells were induced to exit naïve pluripotency and
became “capacitated” for germ layer specification45, their gene
expression profile changed from a pre-implantation-like to a
post-implantation-like epiblast gene signature (Supplementary
Fig. 5b). Overall, our data indicate a progressive pluripotency
transition of the epiblast following implantation, in agreement
with recent studies of human embryos23,46, and expression
profiles observed in mouse and monkey embryos7,8,47.
FGF signalling is required for embryo growth after implanta-
tion. Among the primed pluripotency markers upregulated by the
post-implantation human epiblast (Fig. 1e), FGF2 represents an
important ligand of the fibroblast growth factor (FGF) signalling
cascade as activation of this pathway is required for derivation
and maintenance of human ESC in culture48. Analysis of the
expression of the major ligands and receptors of the FGF family
(Supplementary Data 5) revealed the post-implantation epiblast
as a central source of two major transcripts: FGF2 and FGF4
(Fig. 2a). Epiblast cells expressed low levels of additional FGF
ligands such as FGF8, FGF17, FGF18 and FGF19 (Supplementary
Fig. 6a–d). The corresponding FGF receptors (FGFR1/2/3/4) were
widely expressed in all post-implantation lineages (Fig. 2b), with
particular enrichment of FGFR1 in the hypoblast, suggesting
possible signalling interactions.
To test the functional role of FGF signalling, we cultured
blastocysts from 6 to 8 d.p.f. (48 h) in the presence of one of three
agents: PD-0325901 (PD), which inhibits MEK downstream
of the FGFR; the pan-FGFR inhibitor, LY2874455;49 or a
combination of FGF2, FGF4 and heparan sulphate to stimulate
activation of the FGF signalling cascade. To determine whether
any change in cell numbers was due to inhibitor action or non-
specific cytotoxic effects, embryos were exposed to two different
concentrations of inhibitors: PD at high (3 μM) and lower dose
(1 μM) as previously described7,50, and LY at high (1 μM), as
shown to be able to suppress downstream FGF targets51, and
lower dose (500 nM)52. Either inhibition of MEK by PD or
blockage of the upstream FGF receptors by LY caused a reduction
in cell numbers in both the epiblast and hypoblast lineages
(Fig. 2c–f and Supplementary Fig. 6e, Supplementary Data 6).
While this was observed at the lower concentration of LY,
supplementation of PD at 1 μM had only a mild effect in the
reduction of the number of OCT4-positive cells compared to
control (non-significant). However, supplementation of 1 μM PD
led to a significant reduction of hypoblast cells compared to
control. In contrast to the epiblast and hypoblast, the number of
trophoblast cells was not affected by PD. Because blockage of all
FGFRs by LY caused a reduction in the number of trophoblast
cells, alongside epiblast and hypoblast, we cannot rule out a
potential toxic effect of the drug itself in addition to the effect of
removing FGF signalling entirely. Despite the reduction in cell
number, embryos treated with LY were able to attach and
progress in their development. These results suggest that FGF
signalling is necessary for proliferation of the epiblast, hypoblast
and trophoblast lineages, even though we cannot rule out that the
reduction of hypoblast cells observed could be due to the
reduction of epiblast cells and thereby an indirect effect of FGF
inhibition. The reduction of cell numbers by the upstream
inhibition through LY, which was not replicated when inhibiting
the MEK/ERK downstream signalling at the lower inhibitor
concentration, suggest the activity of additional pathways down-
stream of FGF. We also tested the effect of FGF signalling
activation by addition of exogenous FGF2 and FGF4 to the
culture medium. Treated embryos were comparable in cell
number to controls (Fig. 2 d–f and Supplementary Fig. 6f) but
displayed a reduced variability in the epiblast cell numbers
(Supplementary Fig. 6g), supporting the possibility that FGF may
be beneficial for the development of human embryos in culture.
Molecular characterisation of anterior-like hypoblast cells.
Another major step of post-implantation development involves
pre-patterning of the epiblast before initiation of gastrulation,
which is achieved by the AVE15 via secretion of NODAL, BMP
and WNT antagonists53,54. The region of the epiblast in proxi-
mity to the AVE becomes the future anterior side of the embryo,
while the opposing region becomes the site of the primitive streak
formation. Therefore, we investigated whether a similar signalling
centre may exist in the human hypoblast. Analysis of the single-
cell transcriptomes of the hypoblast lineage identified a sub-
cluster of cells enriched for the expression of CER1 both at 9 and
11 d.p.f. (sub-cluster 0; Fig. 3a, b and Supplementary Fig. 7a, b), a
key NODAL/BMP/WNT antagonist secreted by the mouse55
and monkey11 AVE. Immunofluorescence analysis at 9 d.p.f.
(Fig. 3c, d) confirmed that 17-43% (IQR) of the GATA6-
positive hypoblast cells in contact with the epiblast expressed
CER1 (Fig. 3e–g, Supplementary Data 7). These CER1 positive
cells showed a localisation bias towards one side of the hypoblast
in a subset of embryos (Fig. 3h, Supplementary Fig. 7d–f, Sup-
plementary Video 1). These results suggest that a subpopulation
of cells within the human hypoblast may act similarly to the
mouse AVE by secreting the antagonist CER1.
Fig. 1 Single cell RNA sequencing of post-implantation human embryos and pluripotency transition profile. a Identification of four major clusters
coloured by lineage via UMAP: epiblast (red, 108 cells at 9 d.p.f., 58 cells at 11 d.p.f., total=166), hypoblast (purple, 82 cells at 9 d.p.f., 54 cells at 11 d.p.f.,
total= 136), cytotrophoblast (green, 1956 cells at 9 d.p.f, 226 cells at 11 d.p.f, total=2182), syncytiotrophoblast (cyan, 1058 cells 9 d.p.f., 1278 cells at
11 d.p.f., total= 2336). Number of embryos: n= 8 at 9 d.p.f., n= 8 at 11 d.p.f. Only embryos with all three lineages were analysed, refer to Supplementary
Data 1. b Heatmap displaying z-score values of the most differentially expressed genes between different lineages, alongside known lineage markers. In
bold red the top most enriched genes expressed in a particular lineage as shown in Supplementary Data 2. c Comparisons between pre-implantation single-
cell sequenced epiblast and ICM cells previously published33–36 (cyan inner cell mass (ICM) at 5 d.p.f., green epiblast at 6–7 d.p.f.) versus our post-
implantation datasets (purple epiblast at 9 d.p.f, red epiblast at 11 d.p.f.). Comparison of the expression levels of key markers of naïve pluripotency (d),
primed pluripotency (e) and core pluripotency (f). Bars represent median. g Logistic regression analysis showing quantitative cell matching scores between
human embryo datasets ICM at 5 d.p.f. (blue), pre-Epi at 6–7 d.p.f. (green) and post-Epi at 9 d.p.f. (purple) and at 11 d.p.f. (red) (y-axis) and human
embryonic stem cells H9 and H9-Reset43 (x-axis). Comparison H9 vs H9-Reset by Sidak’s multiple comparisons ad-hoc test for 2 way ANOVA, H9 cells
differ from the H9-Reset throughout stages: 5 d.p.f. (p= 0.0015**), 6–7 d.p.f. (p < 0.0001****), 9 d.p.f. (p= 0.0101*) and 11 d.p.f. (p < 0.0001****). This
difference is highly significant at 6-7 d.p.f., with H9-Reset cells sharing similarities to 6–7 d.p.f. pre-implantion epiblast, and at 11 d.p.f. with H9 cells sharing
similarities with 11 d.p.f. post-implantion epiblast.
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Given the localisation bias of CER1, we sought to investigate
which upstream transcription factors may drive hypoblast
patterning. Using the co-expression and motif-supported pipeline
SCENIC56, we identified 12 transcription factors predicted to
participate in regulation of CER1 expression based on co-
expression networks and the presence of a binding motif
upstream of the CER1 coding sequence (Supplementary Fig. 8a).
The activity of each of these transcription factors was scored by
SCENIC based on the expression of its putative targets in every
single cell, producing a regulon activity score as a proxy for
predicted transcription factor activity (Supplementary Fig. 8b-m;
Red UMAPs). These factors included the transcription factors
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FOXA2, HNF4A, JUNB, SP5 and GSC, which did not show
preferential activity in the CER1-positive hypoblast sub-cluster
(Supplementary Fig. 8b–g, Supplementary Data 9), while the
mouse AVE marker HHEX, as well as FOXA3, LHX1, MIXL1,
MNX1 and SOX21 did show preferential activity in the putative
anterior hypoblast sub-cluster (sub-cluster 0) (Supplementary
Fig. 8h–m, Supplementary Data 9).
To define the gene expression profile of this sub-population in
the hypoblast, we examined the most enriched genes that
characterise the sub-cluster 0 (Supplementary Fig. 9a) and
analysed the correlation between CER1 expressing cells and other
canonical AVE markers57. CER1 expression correlated strongly
with the expression of two major NODAL antagonists, LEFTY1
and LEFTY2 both at 9 and 11 d.p.f., which were also found to be
among the most enriched genes of this sub-cluster, and to a lower
extent with the BMP antagonist NOG, the WNT antagonists
DKK1/4 and HHEX (Fig. 3i and Supplementary Fig. 9b–d), that
are expressed in the mouse AVE58, demonstrating the co-
expression of multiple canonical AVE markers at the RNA level
in the hypoblast. We confirmed that cells secreting LEFTY1
protein at 9 d.p.f. also displayed a localisation bias towards one
side of the hypoblast in a subset of embryos (Fig. 3j–l,
Supplementary Fig. 10a), similar to CER1 secreting cells.
Patterning of the epiblast by anterior-like hypoblast. To
determine whether this group of human hypoblast cells expres-
sing anterior markers is able to exert a similar action as the mouse
AVE in pre-patterning the epiblast before gastrulation, we next
investigated whether canonical targets of signalling pathways
were heterogeneously expressed in the epiblast. We found het-
erogeneous expression of the WNT target AXIN2 (Supplementary
Fig. 11a) as well as of the WNT nuclear effector TCF7 (TCF1)
(Supplementary Fig. 11b). By analysing the BMP targets ID1, ID2,
ID3 and ID4 (Supplementary Fig. 11c–f), we observed hetero-
geneity across the epiblast and restricted expression of ID2 in a
subset of cells. Cells expressing ID2 corresponded to a small
number of cells that showed both SMAD1 (BMP) and SMAD3
(NODAL/TGFβ factor) transcriptional activity (Supplementary
Fig. 11g, h). Cells with active TCF7 and SMAD1 showed overlap,
suggesting that WNT and BMP signalling are active simulta-
neously in the same cells (Supplementary Fig 11i).
To validate the heterogeneous signalling across the epiblast and
visualise its localisation, we investigated the relationship between
CER1 localisation and the activation of the BMP pathway as
marked by the presence of phosphorylated (p)SMAD1.5 (Fig. 3m).
Nuclear pSMAD1.5 was visible in a subset of epiblast cells
(arrows) distanced from CER1 positive hypoblast cells (Fig. 3m,
Supplementary Fig. 10b), whereas OCT4 epiblast cells adjacent to
CER1 positive hypoblast cells were negative for pSMAD1.5.
Together, these data provide support for the existence of a
subpopulation of cells within the human hypoblast that resembles
the mouse AVE and secrets conserved signalling antagonists for
patterning of the epiblast. However, rather than being organised
into a discrete domain as in the mouse embryo57, in human this
group of cells occupies a larger domain preferentially distributed
along one side of the hypoblast. We term these cells the human
putative anterior hypoblast signalling centre.
Establishment of anterior-like hypoblast at 7 d.p.f. The estab-
lishment of the AVE in the mouse is preceded by the formation of
the DVE at the distal tip of the epiblast53,54,59. The anterior side
becomes specified through the migration of DVE cells towards
the proximal pole of the embryo14,60. To investigate the dynamics
driving the formation of the putative human anterior hypoblast
over time, we examined the distribution of CER1-expressing cells
upon attachment of the embryo at 7 d.p.f. 69–82% (IQR) of the
GATA6-positive hypoblast cells in contact with the epiblast
expressed CER1 (Fig. 4a–c, Supplementary Data 10), as opposed
to 17–43% in embryos at 9 d.p.f. (Fig. 3g). The CER1 expressing
cells occupied a widespread domain across the hypoblast at
7 d.p.f. (Fig. 4d and Supplementary Fig. 12a, b). This is in contrast
to the discrete domain of the mouse DVE and appears to
resemble, instead, the pattern observed in the hypoblast
of cynomolgus monkey11 and chick embryos61,62. Examination of
their angular distribution revealed that CER1 expressing cells at
7 d.p.f. did not show any localisation bias (average cellular dis-
tribution of 91°) (Fig. 4e, Supplementary Fig. 13a–c), whereas the
position of the CER1 domain became shifted towards one side of
the epiblast at 9 d.p.f. (average 71°) (Supplementary Fig. 13d).
These data suggest a model where CER1 occupies a significantly
wider domain of the hypoblast at 7 d.p.f. and becomes asymme-
trically localised to one sideat 9 d.p.f. (Fig. 4f).
Discussion
Our large scRNA-seq dataset of human embryos generated in this
study allowed us to investigate key signalling events underlying
human post-implantation development. We first focused on the
pluripotency state transition of the human epiblast as it develops
beyond implantation. This revealed that the downregulation
of naïve genes is accompanied by the upregulation of early
post-implantation primed factors, in agreement with previous
results23,24. This pluripotency transition is needed for epiblast epi-
thelialisation, as we have previously shown32, and is recapitulated
Fig. 2 FGF signalling is required for proliferation during post-implantation development. a/b UMAPs showing expression levels of main FGF ligands
(FGF2/4) (a) and receptors (FGFR1/2/3/4) (b). The epiblast is a source of FGF2/4. FGF receptors (FGFR1/2/3/4) are widely expressed throughout all the
lineages, with FGFR1 being the most highly expressed. c Immunofluorescence of human embryos at 8 d.p.f. cultured in DMSO control, in MEK inhibitor
PD0325901 at 3 and 1 μM, in pan-FGFR inhibitor LY2874455 at 1 μM and 500 nM, in FGF2/4+heparan sulphate proteoglycans. On the left: zoom-out
maximum projection, on the right z-sections. Number of experimental replicates: 9. d–f Quantification of the cell number for the epiblast marked by OCT4
(d), hypoblast by SOX17 expressing cells in contact with the basal side of epiblast (e), and trophoblast (negative for OCT4/SOX17) (f). Statistical test:
two-tailed Kruskal–Wallis test with Dunn’s correction. d Inhibition by PD 3 μM causes significant reduction of OCT4 cells, non-significant at 1 μM: p=
0.0026 (**) control vs PD 3 μM. Inhibition by LY causes a significant reduction both at 1 μM and 500 nM: p= 0.0006 (***) control vs LY 1 μM, p= 0.0109
(*) control vs LY 500 nM. Non-significant difference when supplemented with FGF2/4. e Inhibition by PD causes a significant reduction of SOX17 cells
both at 3 μM and 1 μM: p= 0.0023 (**) control vs PD 3 μM, p= 0.0203 (*) control vs PD 1 μM. Inhibition by LY causes a significant reduction both at 1 μM
and 500 nM: p= 0.0011 (**) control vs LY 1 μM, p= 0.0002 (***) control vs LY 500 nM. Non-significant difference when supplemented with FGF2/4.
f Inhibition by PD does not cause a significant reduction in trophoblast cells, either at 3 μM or 1 μM. Inhibition by LY causes significant reduction only at
500 nM: p= 0.0015 (**) control vs LY. Non-significant difference when supplemented with FGF2/4. Box represents the 25th–75th percentiles interval,
middle line the median, cross represents the mean, whiskers show the minimum and maximum values, dots represent individual embryos. Number of
embryos: control (n= 19), PD 3 μM (n= 12), PD 1 μM (n= 15), LY 1 μM (n= 8), LY 500 nM (n= 8), FGF2/4 (n= 7). Scale bars: 50 μm (Fig. 2c) and
25 μm (Fig. 2c i–ii, zoom). Source data are provided as a Source Data file.
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by different pluripotent states of human ESCs in culture3. Inter-
estingly, no cells were similar to the peri-implantation epiblast
suggesting a possible intermediate pluripotent state that is difficult
to capture25. Such a state could potentially correspond to a ‘rosette
stage’ recently described in mESCs63.
In contrast to the specification of the primitive endoderm in
mouse64–66, FGF/ERK signalling has been shown to be dis-
pensable for the lineage segregation between epiblast and hypo-
blast in the human embryo50,67. However, here we find that FGF
signals are necessary for growth and proliferation of the epiblast,
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hypoblast and trophoblast during early post-implantation devel-
opment. We cannot exclude that FGF may play also a role in fate
specification as complete lineage segregation between the epiblast
and hypoblast occurs only upon implantation68. In agreement
with this, a recent study reported that FGF signalling is required
for the differentiation of naïve human ESCs to a hypoblast-like
fate46,69. In addition to ERK, FGF signalling may also activate
the AKT cascade, which is necessary for human embryo
pre-implantation development70. Supplementation of IGF1 to
activate the AKT cascade has been suggested as a potential
replacement of FGF supplementation for human ESC culture70.
Given the use of IGF1 in our culture media, the decrease in the
epiblast cell numbers variability when supplementing additional
FGF, and the strong effect of both FGF inhibitors, we conclude
that IGF1 and FGF signalling may have intersecting rather than
redundant roles.
The results we present here identify the existence of a group of
hypoblast cells that express antagonists of the BMP, NODAL and
WNT signalling pathways, such as CER1 and LEFTY1 (Fig. 4f),
which may induce pre-patterning of the epiblast to establish the
AP axis of the human embryo. This step is of fundamental
relevance for the initiation of gastrulation, as the primitive streak
will form at the site distal from this putative signalling centre.
Future studies will be required to dissect the mechanism by which
this putative anterior signalling centre patterns the epiblast and
regulates establishment of the AP axis. However, in contrast to
the mouse where the DVE is established at the distal pole of the
egg cylinder as a discrete domain53,54,59, the pattern of gene
expression in humans occupies a widespread domain at 7 d.p.f.,
reminiscent of the pattern observed in the hypoblast of cyno-
molgus monkey11 and chick embryos61,62. It would be important
in future studies to determine the mechanism underlying the shift
in localisation towards one side of the epiblast at 9 d.p.f.. This
could occur as a result of a local downregulation of CER1 from an
initially widespread expression, causing only one side of the
hypoblast to retain its expression, or, alternatively, be a con-
sequence of the uneven expansion of GATA6+/CER1- cells in
comparison to GATA6+/CER1+ cells.
While our data highlights the possible function of the hypo-
blast in mediating epiblast patterning via secreted inhibitors, the
role of the trophoblast and amnion as a source of BMP and WNT
signals remains to be explored. In cynomolgus monkey embryos
the cytotrophoblast secretes WNT3a while the amnion acts as a
source of both BMP4 and WNT3a11. Interestingly, in humans
WNT3a is not highly expressed in the cytotrophoblast as in the
monkey, raising further questions of the role and action of
different WNTs in the human specific context. Overall, our study
points to signalling interactions in the developing human embryo
leading up to gastrulation.
Methods
Ethics statement. Human embryo work was done in accordance with Human
Fertility and Embryology Authority (HFEA) regulations (license reference R0193).
Ethical approval was obtained from the ‘Human Biology Research Ethics Com-
mittee’ of the University of Cambridge (reference HBREC.2017.21). Informed
consent was obtained from all participants in the study. These were patients
from the CARE Fertility Group, Bourn Hall and Herts & Essex fertility clinics,
which had supernumerary embryos after completing their IVF treatment. Prior to
giving consent, patients were informed about the specific objectives of the project,
and the conditions that apply within the license. They were also offered counselling
and did not receive any financial inducements. Embryo cultures were always
stopped before day 14 and prior to the appearance of any signs of primitive streak
formation.
Human embryo thawing. Cryopreserved day 5 or day 6 human blastocysts were
received at the University of Cambridge and thawed using Kitazato thaw kit
(VT802-2, Hunter Scientific) following the manufacturer’s instructions. The day
before thawing, the TS (Thawing) solution was placed at 37 °C and Global Total
human embryo culture medium (HGGT-030, LifeGlobal group) was incubated at
37 °C+ 5% CO2. Upon thawing, human embryos were immersed in 1 mL of the
pre-warmed TS solution for 1 min. They were subsequently transferred to DS
(Dilution) solution for 3 min, WS1 (Washing step 1) solution for 5 min and WS2
(Washing step 2) solution for 1 min. All these incubation steps were done using
reproplates (REPROPLATE, Hunter Scientific). Thawed embryos were incubated
in pre-equilibrated Global Total human embryo culture medium under mineral oil
(9305, Irvine Scientific) for 4 h to allow recovery. Culture conditions are the fol-
lowing: 37 °C 20% O2 and 5% CO2 in a humidified atmosphere.
Post-implantation culture of human embryos. 4 h following the thawing, the
zona pellucida was removed by briefly treating the embryos with acidic Tyrode’s
solution (T1788, Sigma). Embryos were cultured in pre-equilibrated in vitro culture
1 (IVC1) culture medium (M11-25, Cell Guidance Systems). We introduced a
modification to our original IVC1 recipe6 consisting of the addition of 50 ng/mL of
Insulin Growth Factor 1 (IGF-1) (78078, STEMCELL Technologies), as this
improved the preservation of epiblast and hypoblast cells in culture. Embryos
were cultured in 8 well μ-slides tissue culture wells (80826, Ibidi) in approximately
300 μL volume per embryo per well. Half-media changes with IVC1 supplemented
with IGF-1 were done every 24 h.
Limitations of the culture system and exclusion criteria for the analysis. In
this study we used supernumerary embryos donated from couples undergoing
IVF treatment. As a consequence, several embryos degenerated upon thawing or
during the culture before reaching the desired final stage. These were usually
unable to attach to the dish, showed clear signs of cell death and were therefore
excluded from the analysis. Regarding the embryos included in the analysis, it is
important to consider the variability in sample quality that exists among different
embryos and patients. This should be taken into consideration for the inter-
pretation of the data of the study. Another source of variability is the culture
condition. This warrants further optimisation to support optimal development of
the human embryo post-implantation which is currently lacking.
Fig. 3 Characterisation of the putative anterior hypoblast in human embryos at 9 d.p.f. a UMAP of hypoblast cells subdivided into sub-clusters 0-2. Most
enriched genes expressed in each sub-cluster are reported in Supplementary Data 8. b Sub-cluster 0 expresses CER1. c, d Immunofluorescence at 9 d.p.f.:
CER1 is expressed asymmetrically in a subset of hypoblast cells (GATA6+). N (experimental replicates): 3. N(embryos): 19 e, Quantification CER1+ cells
(n= 19 embryos, mean in red ± SEM). f Quantification hypoblast cells (GATA6+) in contact with basal epiblast (n= 19 embryos, mean in red ±SEM).
g Percentage of CER1+ cells versus total hypoblast cells per embryo. Boxes represent the 25th/75th percentiles, red line the median, cross the mean,
whiskers the min/max, dots individual embryos (n= 19); N(experimental replicates): 3. Source data provided as a Source Data file. h Quantification
of angular distribution of CER1+ cells along the hypoblast hemisphere (0° to 180°). N(embryos) n= 28, combined from Supplementary Figure 7f (all
embryos included). CER1+ cells show a significant localisation bias towards one side of the hypoblast in 10/28 embryos (Supplementary Figure 7f).
i, Correlation analysis of CER1 with WNT, BMP and NODAL antagonists. Co-expression corrected by Benjamini–Hochberg: significant correlations between
CER1 and LEFTY1 (p= 4.21E−13), LEFTY2 (p= 2.75E−10), HHEX (p= 1.88E−07), NOG (p= 1.39E−08), DKK4 (p= 4.41E−07), DKK1 (p= 1.65E−05), SFRP1 (p=
0.0047). Correlation with NCLN, CHRD and SOSTDC1 are ns. j Immunofluorescence of LEFTY1 at 9 d.p.f.. N(experimental replicates): 3. N(embryos): 7.
k Quantification of LEFTY1+ cells (n= 7 embryos, mean in red ± SEM). l Quantification of angular distribution of LEFTY1+ cells along the hypoblast
hemisphere. N(embryos) n= 7, combined from Supplementary Fig. 10a. LEFTY1+ cells showed a statistically significant localisation bias in 2/7 embryos
(Supplementary Figure 10a).m Immunofluorescence at 9 d.p.f. of nuclear pSMAD1.5 in a subset of OCT4+ cells (arrows) distant from CER1 domain, where
pSMAD1.5 is not detected. N(experimental replicates): 8. N(embryos) stained for pSMAD1.5= 29; 9/29 embryos (31%) show pSMAD1.5 in OCT4+ cells;
8/9 embryos (89%) display localisation of pSMAD1.5 distant to CER1. Scale bars: 50 μm (Fig. 3c,j, Fig. 3d,m (left)), 25 μm (Fig. 3d,m (right)). Source data
are provided as a Source Data file.
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Fig. 4 Characterisation of the putative anterior hypoblast in the human embryos at 7 d.p.f. a Quantification of the number of CER1 expressing cells (n=
13 embryos, mean in red ± SEM). b Quantification of the number of hypoblast cells as GATA6+ cells lining the basal side of epiblast (n= 10 embryos, mean
in red ±SEM). c Percentage of hypoblast cell expressing CER1. Boxes represent the 25th and 75th percentiles, red line the median, cross the mean, whiskers
the min and max values, dots individual embryos (n= 10 embryos). N experimental replicates: 5. d Immunofluorescence analysis of embryos at 7 d.p.f.
reveals the widespread distribution of CER1 cells along the hypoblast, marked by GATA6 along the basal side of the epiblast epithelium (ii). N experimental
replicates: 5. N(embryos) analysed: 13 e Quantification in 3D of the angular distribution of CER1 expressing cells along the hypoblast hemisphere at 7 d.p.f.
(0° to 180°). N embryos: 10. fModel of the establishment of the putative anterior hypoblast centre: initially at 7.d.p.f. the putative anterior hypoblast centre
is radially expressed throughout most of the cells of the hypoblast and particularly enriched distally. At 9.d.p.f. the putative anterior hypoblast centre
becomes localised asymmetrically to one side of the hypoblast, repressing the activity of key signalling pathways such as BMP on the adjacent epiblast.
Asymmetric activity may discriminate the future anterior region from the prospective posterior region of the epiblast, where gastrulation will occur. Scale
bars: 50 μm (4a, zoom out), 25 μm (4d, i–xii). Source data are provided as a Source Data file.
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Inhibitor treatments. For the analysis presented in Fig. 2, the culture medium has
been supplemented with DMSO for control group; with 3 μM or 1 μM PD0325901
(PD, Stem Cell Institute, Cambridge) as reported in other studies of MEK
inhibition;50 with LY287445 (ab216313, Abcam) to inhibit all FGF receptors, at
1 μM, as shown to be able to inhibit pERK51, and at 500 nM52. To stimulate FGF
signalling, the medium has been supplemented with FGF2 (Stem Cell Institute) at
25 ng/ml, FGF4 (R&D systems, 67-202) at 25 ng/ml and Heparin (Sigma H3149) at
1×. Apart from degeneration during the culture as discussed above, all embryos
reaching stage 8 d.p.f. have been included in the analysis presented in Fig. 2. For all
the other experiments presented, only embryos with clear epiblast and hypoblast
were included in the analysis. Embryos, which have successfully attached by the
end of the culture but lack either epiblast or hypoblast or show clear signs of
degeneration have been excluded and are not accounted for the n number reported
in this study.
Single cell isolation from in vitro cultured human embryos. Embryos were
cultured from 5 d.p.f. as above until either 9 or 11 d.p.f.. At the end of the culture,
each embryo was gently detached from the bottom of the ibidi slide using a thin
plastic needle and incubated in 500 μL of pre-equilibrated 0.5% Trypsin EDTA
(25300054, Life Technologies) at 37 °C for 10 min. The reaction was stopped by
transferring the embryos in PBS+ 1% PVP (polyvinylpyrrolidone) or 0.1% BSA.
The embryo was dissociated into single cells by mechanical pipetting using 50 μm
diameter tips (MXL3-IND-50, Origio). The single cell suspension was loaded in the
10x-Genomics Chromium for encapsulation. The 10x-Genomics v2 or v3.0
libraries were prepared as per the manufacturer’s instructions. Embryos labelled as
‘mplex’ in Supplementary Data 1 were multiplexed under the same reaction.
Libraries were sequenced, aiming at a minimum coverage of 50,000 raw reads per
cell, on an Illumina HiSeq 4000 (paired-end; read 1: 26 cycles; i7 index: 8 cycles, i5
index: 0 cycles; read 2: 98 cycles).
Single cell RNA-seq data analysis. Single-cell RNA-sequencing was performed
using the 10X Genomics Chromium system. Reads were aligned against GRCh38
and transcript abundances counted using the Cell Ranger software suite (version
2.2). Cells for which expression of mitochondrial genes accounted for more than
20% of total expression or cells with fewer than 1000 detectable genes were
removed from the dataset (Supplementary Fig. 1f–h). A total of 29 embryos was
submitted for scRNAseq (Supplementary Data 1). We used strict filtering criteria:
only 16 out of 29 embryos were included for analysis based on the presence of all
three lineages (epiblast, hypoblast and trophoblast) to ensure viability of the
embryos and preservation of signalling crosstalk between lineages. The final ana-
lysis includes 16 embryos: 8 embryos at 9 d.p.f. and 8 embryos at 11 d.p.f. as
presented in Supplementary Data 1. Embryos that were sequenced in a multiplexed
fashion were computationally demultiplexed using the souporcell algorithm71,
which clusters the cells by an inferred genotype without the need for a reference
genotype.
Further downstream analyses were performed in the R package Seurat72(version
3.1.5). Batch correction relied on identification of integration anchors73. Cell
clusters were identified using a shared nearest neighbour graph approach based on
the aligned components, as implemented in the ‘FindClusters’ function. Within this
function, the resolution parameter was set such that the resulting clustering
captured most of the biological variance, without over-splitting the data. This
amounted to a resolution parameter of 0.05. Single-cell data was further visualised
using the UMAP dimensionality reduction, as determined by the ‘RunUMAP’
function in Seurat. Cluster-defining genes were identified using the FindAllMarkers
function.
Data from Takashima et al.43 was aligned to GRCh38 using kallisto74. Integrated data
on ICM and epiblast cells from Stirparo et al.33 was subjected to the same workflow
within Seurat as described before to integrate with our data. Data from Xiang et al.23 and
Zhou et al.24, was subjected to the same workflow in Seurat as described above to visualise
gene expression. Cell line data from Takashima et al.43, Theunissen et al.75 and
Rostovskaya et al.45 were mapped onto the epiblast clusters using a logistic regression
framework74. Embryo clusters from Xiang et al.23, and Zhou et al.24 were mapped onto
our embryo clusters using the same logistic regression framework. To identify
transcription factor regulons and score their activity in single cells as presented in
Supplementary Fig. 8, the SCENIC pipeline was employed with default settings. The area
under the curve score for each regulon was then used to create a new assay in the Seurat
object for visualisation of specific regulon activity on the previously generated UMAP.
Embryo fixation and immunostaining. Human embryos were fixed at day 9 of
development in 4% paraformaldehyde (11586711, Electron Microscopy Sciences)
for 20 min. They were permeabilised in PBS containing 0.3% Triton X-100 and
0.1 M glycine (permeabilisation buffer) for 30 min at room temperature. Samples
were blocked for 1 h in PBS containing 1% bovine serum albumin (BSA) and 0.1%
Tween and incubated with primary antibodies diluted in blocking buffer. Fluor-
escently conjugated Alexa Fluor secondary antibodies (ThermoFisher Scientific)
were incubated for 2 h at room temperature in blocking buffer. The following
primary antibodies were used: goat polyclonal anti CERBERUS1 (AF1075, R&D
Systems, 1/200), goat polyclonal anti GATA6 (AF1700, R&D Systems, dilution
1/200), goat polyclonal anti LEFTY1 (AF746, R&D Systems, dilution 1/200), mouse
monoclonal anti OCT3/4 (sc-5279, Santa Cruz Biotechnology, dilution 1/200),
mouse monoclonal anti PODOCALYXIN (MAB1658, clone 222328, R&D Systems,
dilution 1/500), rabbit monoclonal anti Phospho-Smad1 (Ser463/465)/ Smad5
(Ser463/465)/ Smad9 (Ser465/467) (D5B10, Cell Signalling Technology, dilution
1/100) and goat polyclonal anti SOX17 (AF1924, R&D Systems, dilution 1/200).
Where indicated secondary antibodies were incubated together with Alexa Fluor
488/594 phalloidin (A12379, ThermoFisher Scientific, dilution 1/500) and DAPI
(D3571, ThermoFisher Scientific, dilution 1/1000).
For pSmad1.5 staining embryos were fixed for 15 min in 4% PFA, washed 3× in
PBST, and subsequently incubated in 100% MeOH for 10 min. After rehydration in
PBST, the embryos were permeabilised for 15 min in permeabilisation buffer. All
solutions including blocking buffer were supplemented with cOmplete protease
inhibitor (11836153001, Sigma Aldrich, dilution 1/1000).
Image quantification and analysis. Immunofluorescence images were processed
and analysed using Fiji software76 (http://fiji.sc). Cell number as presented in
Fig. 3f–h and Fig. 4b–d was counted manually using the multi-point Cell Counter
plugin in Fiji. To define the hypoblast, only GATA6+ cells lining and in direct
contact with the basal distal side of the epiblast were counted, as opposed to the
total GATA6+ cells, which includes parietal lineage. CER1+ cells in contact with
the epiblast were counted with DAPI as nuclear reference. For each embryo, the
number of GATA6+ hypoblast cells expressing CER1 was calculated as percen-
tages as presented in box plots in Figs. 3g and 4c. The angle distribution of CER1
positive cells was quantified by using the 3D viewer of the SP8 Leica Lightning
software as described in Supplementary Figs. 7 and 12. The epiblast was oriented in
3D in respect to the hypoblast to determine the proximal vs distal plane (where
hypoblast is present). The angle for CER1 positive cells was determined by using
the proximal plane and the middle point of the proximal surface of the epiblast as
reference points. Angles are presented as frequency distributions (from 0° to 180°)
plotted using Matlab software. To compare different embryos, 0° is taken as a
reference point as the side where the majority of CER1 cells are localised along the
entire hypoblast length (from 0° to 180°), defined by GATA6.
Statistics and reproducibility. The exact number of embryos sequenced is indi-
cated in Supplementary Data 1. No statistical method was used to predetermine
sample size. Embryos that did not expand after thawing were excluded from
downstream analyses. The investigators were not blinded to group allocation
during experiments and outcome assessment. For the analysis of immuno-
fluorescence images, the normality of the data was determined using a D’Agostino
Pearson normality test. Data not normally distributed were analysed by the non-
parametric Kruskal–Wallis test with Dunn’s correction. Data shown as boxes
represent the 25th and 75th percentiles interval with the line in the middle of the
box as the median, the cross represents the mean, whiskers show the minimum and
maximum values, dots represent individual embryos. Statistical significance:
p < 0.05 was considered statistically significant (*), p < 0.01 (**), p < 0.001 (***),
p < 0.0001 (****). Statistical analyses were done in Prism (GraphPad) and R.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The raw sequencing and expression-count data with cell classifications have been
deposited at the ArrayExpress database under accession code: E-MTAB-8060. Datasets
can be visualised through the web portals www.humanembryo.org.
Regarding previously published datasets used here, single-cell RNA-sequecning data
from Xiang et al.23 and Zhou et al.24 are deposited in Gene Expression Omnibus
(GEO) under accession numbers GSE136447 and GSE109555, respectively. In
addition, cell line data from Takashima et al.43 are deposited at Array Express under
accession number E-MTAB-2857. Cell line data from Theunissen et al.75 are deposited
at GEO under accession number GSE59435. Cell line data from Rostovskaya et al.45
are deposited in GEO under accession number GSE 123055.
Immunofluorescence data will be available from the corresponding authors upon
reasonable request. Source data are provided with this paper.
Code availability
Custom scripts used for analyses have been deposited at https://github.com/TimCoorens/
EarlyEmbryo_scRNA (https://doi.org/10.5281/zenodo.4738657)77. This repository is
linked to Zenodo and citable as Molè et al. A single cell characterisation of human
embryogenesis identifies pluripotency transitions and putative anterior hypoblast centre.
To align reads, reference assembly GRCh38 was used [https://www.ncbi.nlm.nih.gov/
assembly/GCF_000001405.26/].
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